Oncology
12 Questions with Julia Jakl
Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles
Pharma news highlights: Gleevec, pay-to-delay, human gene patents and data analysis errors

Pharma news highlights: Gleevec, pay-to-delay, human gene pa...

This month, Ed Silverman discusses the issues within the pharma industry around pay-to-delay, the Gleevec decision, human gene patenting and data analysis errors for Diovan. Various legal matters have dominated headlines since our last appearance here. The most prominent, of course, involved a…

Articles
chris-helfrich

Spotlight on... malaria

Our latest ‘spotlight on’ coincides with our April focus on infectious diseases, taking a look into the causes, symptoms and treatments of malaria. It is hard to imagine that a single mosquito bite could end your life. But for thousands of people in the...

Sales & Marketing

Sales & Marketing
Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
12 Questions with Julia Jakl
Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Patients

R&D